The results showed BTN2A2 was associated with the CTLA4, MHC, chemokine, JAK-STAT signaling pathways, antigen processing and presentation, PD1 blockade cancer immunotherapy, immune cells-microRNAs interactions in the TME, and apoptosis (Figure 6A–6I). The gene discussed is CTLA4; the disease is cancer.